| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/28/2004 | US20040214171 Cat kidney disease marker |
| 10/28/2004 | US20040214170 Method for effecting site-directed mutagenesis |
| 10/28/2004 | US20040214169 Method of judging flocculating properties of bottom brewer's yeast |
| 10/28/2004 | US20040214166 Microarray which screens for presence of activated gene regulatory proteins in cells |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214164 Serum biomarkers of Hepatitis B Virus infected liver and methods for detection thereof |
| 10/28/2004 | US20040214163 Expression vector coding hepatitis c or lymphoma viral nucleotide sequences for use as tool in generating antibodies for use in kit which detects viral infection; vircides and immunotherapy |
| 10/28/2004 | US20040214161 Using nucleotide sequence amplification to identify herpes virus sequence in bodily fluids; diagnosing//prognosing cell proliferative disorders |
| 10/28/2004 | US20040214160 Using viruses to detect or purify proteins |
| 10/28/2004 | US20040214158 Treatment of human papillomavirus (hpv)-infected cells |
| 10/28/2004 | US20040214155 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 10/28/2004 | US20040214019 Covalently attaching to the surface a functionalized silicon compound include at least one activated silicon group and at least one derivatizable functional group |
| 10/28/2004 | US20040213809 Method of treating diseases connected with immunity deficiency |
| 10/28/2004 | US20040213808 immunogenic compositions containing as active ingredients recombinantly-produced forms of truncated flavivirus envelope and non-structural glycoproteins; may also include an adjuvant, such as saponin or a saponin-like material |
| 10/28/2004 | US20040213794 Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease |
| 10/28/2004 | US20040213766 Compositions and methods for treating transplants |
| 10/28/2004 | US20040213763 administering intravenously to the mammal an adenoviral vector comprising a DNA sequence encoding a leptin operably linked to a promoter and expressing the DNA sequence, for treating obesity in a mammal having a deficiency in functional leptin |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | US20040213741 Dna sequences; gene expression; therapy for trauma injuries |
| 10/28/2004 | US20040213739 Screening for modulator of alzheimer's disease; obtain human, administer mdulator, monitor and evaluate humans response to modulator |
| 10/28/2004 | US20040211940 Plasminogen Activator Assay Involving an Elastase Inhibitor |
| 10/28/2004 | US20040211727 Method for the extra-corporeal qualitative and/or quantitative recording of neurotoxic substances in the blood plasma of an individual |
| 10/28/2004 | US20040211666 Cross-linked enzyme matrix and uses thereof |
| 10/28/2004 | DE10316159A1 Analysis of nucleic acid by incorporation of luminescent dye during extension, useful especially for analysis of point mutations, is done on an optical waveguide chip in a flow cell |
| 10/28/2004 | DE10221435B4 Enzymelektrodenanordnung, ein Verfahren zu deren Herstellung sowie eine diese Enzymelektrodenanordnung umfassende Biosensoranordnung Enzyme electrode assembly, a process for their preparation and a comprehensive array biosensor this enzyme electrodes |
| 10/28/2004 | CA2523693A1 Bacteriophage for lysis of methylobacterium and compositions and uses thereof |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2522802A1 Biologically active substance-immobilized device |
| 10/28/2004 | CA2522725A1 Polynucleotides for the detection of listeria monocytogenes |
| 10/28/2004 | CA2522689A1 Oligonucleotides for the detection of salmonella species |
| 10/28/2004 | CA2522680A1 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 10/28/2004 | CA2522653A1 Methods of identifying spike morphology and fusarium head blight resistance, and the use of these methods for improving barley and related triticeae plants |
| 10/28/2004 | CA2522629A1 Method and kit for molecular identification of smallpox |
| 10/28/2004 | CA2522552A1 Insulin-induced gene as therapeutic target in diabetes |
| 10/28/2004 | CA2522483A1 Method for identifying ligands specific for structural isoforms of proteins |
| 10/28/2004 | CA2522299A1 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 10/28/2004 | CA2522290A1 Medical device for monitoring blood phenylalanine levels |
| 10/28/2004 | CA2522215A1 Methods for identifying therapeutic targets involved in glucose and lipid metabolism |
| 10/28/2004 | CA2521812A1 Optimal polyvalent vaccine for cancer |
| 10/28/2004 | CA2521757A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same |
| 10/28/2004 | CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 10/28/2004 | CA2521084A1 Global amplification using a randomly primed composite primer |
| 10/28/2004 | CA2520538A1 Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup |
| 10/28/2004 | CA2519696A1 Methods of assessing crohn's disease patient phenotype by i2, ompc and asca serologic response |
| 10/28/2004 | CA2518961A1 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject |
| 10/28/2004 | CA2518760A1 Method for examining obesity or leanness |
| 10/28/2004 | CA2518529A1 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 10/28/2004 | CA2515850A1 Reduction of migration shift assay interference |
| 10/28/2004 | CA2497152A1 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 10/27/2004 | EP1471444A1 Rna sequence analyzer, and rna sequence analysis method, program and recording medium |
| 10/27/2004 | EP1471355A1 Method of fixing biomolecule to carrier |
| 10/27/2004 | EP1471349A2 Potentiometric sensor device for pH measurement |
| 10/27/2004 | EP1471154A2 Breast cancer prognostics |
| 10/27/2004 | EP1471153A2 Transcriptional activity assay |
| 10/27/2004 | EP1471152A1 Mutations in the human PCSK9 gene associated to hypercholesterolemia |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471144A1 Biological variability of asthma associated factor, AAF2 (IL-9 receptor), useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470419A1 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 10/27/2004 | EP1470255A2 Identification of cell differentiation states based on methylation patterns |
| 10/27/2004 | EP1470254A2 Method for the analysis of cytosine methylation patterns |
| 10/27/2004 | EP1470251A2 Exponential amplification of nucleic acids using nicking agents |
| 10/27/2004 | EP1470250A2 Gene expression analysis using nicking agents |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470248A2 Methods for reducing contamination by genetically modified plant products |
| 10/27/2004 | EP1470247A2 Novel genetic markers for leukemias |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470245A2 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 10/27/2004 | EP1470244A1 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 10/27/2004 | EP1470243A2 Nucleotide detection method |
| 10/27/2004 | EP1470242A2 Enzymatic cycling assays for homocysteine and cystathionine |
| 10/27/2004 | EP1470241A2 Method, system and knowledge repository for identifying a secondary metabolite from a microorganism |
| 10/27/2004 | EP1470240A2 Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2 |
| 10/27/2004 | EP1470239A2 Psoriasin expression by breast epithelial cells |
| 10/27/2004 | EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells |
| 10/27/2004 | EP1470219A2 Peroxide-driven cytochrome p450 oxygenase variants |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470215A2 Lid element |
| 10/27/2004 | EP1470160A2 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 10/27/2004 | EP1470158A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 10/27/2004 | EP1470156A2 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease |
| 10/27/2004 | EP1470155A2 Pluripotency determining factors and uses thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof |
| 10/27/2004 | EP1469878A2 Fgfr agonists |
| 10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 10/27/2004 | EP1469872A2 Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptilbility |
| 10/27/2004 | EP1469870A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469810A2 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 10/27/2004 | EP1469769A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1437368A4 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 10/27/2004 | EP1404866A4 Bioassay for myostatin |
| 10/27/2004 | EP1276894B1 Method for screening of microorganisms under nutrient limited conditions |
| 10/27/2004 | EP1177423A4 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
| 10/27/2004 | EP1171627B1 Assay for measuring different enzyme activities simultaneously |
| 10/27/2004 | EP1166076A4 Snp detection |
| 10/27/2004 | EP1157132A4 Aptamers as reagents for high throughput screening |
| 10/27/2004 | EP1097209B1 Inhibition of alopecia |